What's New - HKAPI

07 Oct 22

Extraordinary General Meeting 2022

An online EGM was called by the HKAPI Board to pass a resolution to adopt the new Code of Practice. It was unanimously adopted by members with immediate effect.

06 Sep 22

Appointment of New Board Member

HKAPI is pleased to announce that Mr. Howard Lin has been elected as a Board Member of the association to fill the vacancy in the Board with effect from 6th September 2022.

31 Aug 22

Event: AI and Big Data Research for Health Improvement Symposium

Over 200 attendees joined the “AI and Big Data Research for Health Improvement Symposium” held virtually on 30th and 31st August 2022.

11 Jul 22

1st CEO Meeting 2022-2024

The 1st CEO Meeting of the Term (2022-24) was held online on 11 July 2022. More than 20 CEOs and directors from our member companies joined to meet the new HKAPI Board, and exchanged views on the future directions of the Association.

07 Jul 22

Event: The Journey of Biotech Innovation and Investment in Hong Kong

The Hong Kong Association of the Pharmaceutical Industry (HKAPI) is delighted to be one of the supporting organizations of the hybrid event hosted by InvestHK - “The Journey of Biotech Innovation and Investment in Hong Kong” on 7 July.

June 28, 2022
vickyhkapi
No Comments

To ensure members have a thorough understanding of the relevant laws, regulations and Codes regarding medicinal material communicating to the public via different mediums, the HKAPI organises an event with law enforcement authorities and experts to explain the law and its enforcement.

02 Jun 22

Tackling the Threat of Antimicrobial Resistance

The High-Level Steering Committee on Antimicrobial Resistance was set up in 2016 to call for collaboration, synergy and cross-fertilisation of all professional sectors under the "One Health" framework in response to AMR. Ms. Sabrina Chan, the Senior Executive Director of HKAPI has been a member of the Steering Committee since the establishment of the Committee.